Free Access
This article has a note: [https://doi.org/10.1051/radiopro/2017019]


Table 2

Mortality in the French nuclear worker cohort compared to that of the French population, 1968–2004.

Cause of death ICD10 codes n SMR 95%CI
All causes C00–C97 6310 0.60 0.59–0.62
Solid cancers C00–C80, C97, except C46.3 2356 0.68 0.65–0.71
Mouth and pharynx C00–C14, C46.2 109 0.40 0.33–0.49
Oesophagus C15 92 0.45 0.36–0.55
Stomach C16 99 0.70 0.57–0.86
Colon C18 169 0.79 0.67–0.91
Rectum C19–C21 61 0.69 0.53–0.89
Liver C22 116 0.59 0.49–0.71
Gallbladder C23–C24 16 0.70 0.40–1.13
Pancreas C25 139 0.94 0.79–1.11
Peritoneum C26, C45.1, C48 47 0.89 0.65–1.18
Nasal cavity C30–C31 32 0.40 0.27–0.57
Larynx C32 57 0.41 0.31–0.53
Trachea, bronchus and lung C33–C34 595 0.66 0.60–0.71
Pleura C38.4, C45.0 43 1.69 1.22–2.27
Bones and articular cartilage C40–C41 13 0.61 0.33–1.05
Skin melanoma C43 44 1.40 1.02–1.88
Breast (women) C50 70 1.05 0.82–1.33
Corpus uteri (women) C54–C55, C58 12 0.94 0.49–1.65
Ovary (women) C56, C57.0–C57.4, C57.8 21 1.11 0.69–1.70
Prostate (men) C61 149 0.81 0.69–0.95
Bladder C67, C68 56 0.51 0.39–0.66
Kidney C64–C66 70 0.89 0.69–1.12
Brain et central nervous system C70–C72 84 1.03 0.82–1.28
Tumours of lymphatic and hematopoietic tissue      
All C46.3, C81–C96 196 0.81 0.70–0.94
Hodgkin disease C81 17 1.13 0.66–1.82
Non Hodgkin lymphoma C46.3, C82–C85, C88.0, C88.1, C88.3, C91.4, C96 64 0.73 0.56–0.94
Multiple myeloma and IP tumours C88, C88.2, C88.7, C88.9, C90 36 0.97 0.68–1.35
Leukaemia excluding CLL C91.0, C91.2, C91.3, C91.5, C91.7, C92–C95 57 0.69 0.53–0.90
Circulatory diseases G45, I00–I99 1483 0.62 0.59–0.65
Ischemic heart diseases I20–I25 587 0.64 0.59–0.70
Cerebrovascular diseases G45, G45.0–G45.2, G45.8–G45.9, I60–I69 338 0.64 0.58–0.71
Respiratory diseases J00–J99 200 0.41 0.36–0.47
Chronic obstructive pulmonary disease J40–J44, J47 70 0.41 0.32–0.52
Asthma J45–J46 12 0.37 0.19–0.64
Digestive diseases K00–K93 270 0.37 0.32–0.41
Cirrhosis K70 84 0.28 0.22–0.34

ICD10: tenth revision of the International Classification of Diseases; n: observed number of deaths in the cohort; SMR: mortality ratio standardized on calendar period, age, and sex; CI: confidence interval; IP: immuno-proliferative; CLL: chronic lymphocytic leukaemia.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.